Financing (reproduced)
- Categories:Company News
- Author:
- Origin:
- Time of issue:2021-08-12
- Views:0
Overview:First launch丨Hocermed completes over 100 million yuan in Series C financing, Hillhouse Ventures exclusively leads the investment
Financing (reproduced)
Overview:First launch丨Hocermed completes over 100 million yuan in Series C financing, Hillhouse Ventures exclusively leads the investment
- Categories:Company News
- Author:
- Origin:
- Time of issue:2021-08-12
- Views:0
First launch丨Hocermed completes over 100 million yuan in Series C financing, Hillhouse Ventures exclusively leads the investment
Yiou Great Health reported on November 10 that recently, Hocermed (Beijing) Medical Technology Co., Ltd. (“Hocermedl”), a provider of minimally invasive surgical solutions, announced the completion of a Series C financing of more than 100 million yuan. This round of financing was led by Hillhouse Ventures, followed by Gaoke Xinjun, and Haoyue Capital acted as the exclusive financial advisor.
This round of financing will help Hokai Medical accelerate the development and application transformation process in the field of minimally invasive surgery, promote the company's sales channel construction and overseas marketing network construction, and further expand production capacity.
With the gradual penetration of minimally invasive surgery in China, the market demand for minimally invasive surgical instruments is increasing. The prospectus of a number of listed companies shows that the domestic minimally invasive surgical instrument market in 2019 has exceeded 18 billion yuan, 5 years It is expected to reach 40 billion yuan later. However, due to high technical barriers, patent blockade and other reasons, overseas giants represented by Johnson & Johnson and Medtronic account for more than 80% of the market share in this field all year round.
According to Wang Lin, partner of Hi-Tech Xinjun, the minimally invasive surgical ultrasonic scalpel market is ushering in two major changes, one is from repeated use to one-time use, and the other is domestic substitution, which will bring rapid growth in market capacity and market competition. For the reshaping of the pattern, leading domestic companies need to cherish this window of opportunity.
Since its establishment, Hokai Medical has gone through the stages of technology accumulation and clinical transformation, and now has an ultrasonic cutting hemostatic knife system, including two generations of ultrasonic host products, USE, USS, MIC and other series of ultrasonic knives for different departments and indications head. Hocermed said that the quality and technology of their products have been verified by hundreds of large hospitals in China, and they have served hundreds of hospitals all over the world, including Europe and North America.
Hokai Medical will continue to deepen the field of minimally invasive surgery and build barriers in this field. At present, Hokai Medical has provided supporting energy surgical instruments and integrated surgical energy platform products to domestic and foreign surgical robot manufacturers, and entered the field of surgical robots, reflecting its determination to continue to build high barriers in the field of minimally invasive surgery.
As an investor in this round, Hillhouse Capital’s co-chief investment officer and Head of Biomedicine and Medical Devices at Hillhouse Ventures, Yi Nuoqing, said that with the increasing popularity of minimally invasive surgery, surgical energy products represented by ultrasonic scalpels are becoming available in China. Rapid growth and broad application prospects. Since its establishment, Hokai Medical has been focusing on ultrasonic scalpels, accumulated a deep research and development foundation, and established an experienced commercialization team. The special ultrasonic knife for surgical robots that the company is focusing on, represents the combination of energy surgery and surgical robots, and is a manifestation of the development of minimally invasive surgery in the direction of more precision and intelligence.
Yang Zhenjun, partner of Haoyue Capital, said that active equipment + consumables have always been a field with extremely high barriers to medical equipment. The stable ultrasonic scalpel host and ultrasonic scalpel consumables are powerful tools for minimally invasive surgery. In the cooperation with Hocermed, I feel that The Hokai team has made efforts and contributions to provide surgical clinicians with better product performance, and to provide patients with more cost-effective products.
Scan the QR code to read on your phone
Recommended news

Company Address: Tianjin Binhai New District Shinjo West Road No. 5 Zhou Daifuku Financial Center 18 layers 17A-05
E-mail:sales@hocermed.com
Tel:+86-22-59858261
Copyright: ©2021 Hocermed (Tianjin) Medical Technology Co., Ltd.